Giant Cell Tumors Clinical Trials

7 clinical trials for Giant Cell Tumors across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A PHASE III, MULTICENTRE, RANDOMISED, DOUBLE-BLIND STUDY TO ASSESS THE SAFETY AND EFFICACY OF EMACTUZUMAB VS. PLACEBO IN SUBJECTS WITH TENOSYNOVIAL GIANT CELL TUMOUR — RECRUITING · PHASE3
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF ABSK021 TO ASSESS THE EFFICACY AND SAFETY IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR — RECRUITING · PHASE3
• A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF VIMSELTINIB TO ASSESS THE EFFICACY AND SAFETY IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR (MOTION) — RECRUITING · PHASE3
• Network Pharmacology Prediction: Mechanism Study of Puerarin in the Treatment of Giant Cell Tumors of Bone — COMPLETED
• Oral Care of Patients Treated With Anti-RANK-ligand Antibodies for a Giant Cell Tumour — COMPLETED
• Tenosynovial Giant Cell Tumors (TGCT) Observational Platform Project — COMPLETED
• Study of Denosumab in Subjects With Giant Cell Tumor of Bone — COMPLETED · PHASE2

Refine this search